Susquehanna International Group’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$535K Sell
50,990
-2,390
-4% -$23.3K ﹤0.01% 9484
2025
Q4
$614K Sell
53,380
-11,350
-18% -$175K ﹤0.01% 8326
2025
Q3
$1.57M Buy
64,730
+50,400
+352% +$839K ﹤0.01% 6299
2025
Q2
$236K Buy
14,330
+5,460
+62% +$94.3K ﹤0.01% 10884
2025
Q1
$161K Sell
8,870
-5,400
-38% -$154K ﹤0.01% 11157
2024
Q4
$529K Sell
14,270
-26,830
-65% -$1.03M ﹤0.01% 8520
2024
Q3
$1.32M Buy
41,100
+3,840
+10% +$213K ﹤0.01% 6207
2024
Q2
$3.06M Buy
37,260
+16,140
+76% +$1.75M ﹤0.01% 4276
2024
Q1
$3.06M Buy
21,120
+4,850
+30% +$410K ﹤0.01% 4478
2023
Q4
$1.5M Sell
16,270
-13,190
-45% -$1.34M ﹤0.01% 6016
2023
Q3
$4.86M Buy
29,460
+26,850
+1,029% +$3.49M ﹤0.01% 3578
2023
Q2
$165K Sell
2,610
-5,120
-66% -$310K ﹤0.01% 10472
2023
Q1
$263K Buy
7,730
+4,650
+151% +$243K ﹤0.01% 10018
2022
Q4
$178K Buy
3,080
+1,440
+88% +$89K ﹤0.01% 10291
2022
Q3
$154K Buy
+1,640
New +$233K ﹤0.01% 11195
2022
Q2
Sell
-1,510
Closed -$830K 12964
2022
Q1
$830K Buy
1,510
+400
+36% +$242K ﹤0.01% 7618
2021
Q4
$734K Sell
1,110
-1,190
-52% -$910K ﹤0.01% 8120
2021
Q3
$1.93M Sell
2,300
-710
-24% -$720K ﹤0.01% 5916
2021
Q2
$3.82M Buy
3,010
+550
+22% +$621K ﹤0.01% 4529
2021
Q1
$2.7M Sell
2,460
-880
-26% -$1.16M ﹤0.01% 5204
2020
Q4
$4.77M Sell
3,340
-2,160
-39% -$2.3M ﹤0.01% 3471
2020
Q3
$3.88M Sell
5,500
-1,260
-19% -$916K ﹤0.01% 3418
2020
Q2
$4.73M Buy
6,760
+3,970
+142% +$2.29M ﹤0.01% 3085
2020
Q1
$975K Buy
+2,790
New +$1.98M ﹤0.01% 5468

Other funds holding CDLX

Susquehanna International Group's CDLX Position: Q1 2026 in Review

Susquehanna International Group reduced its Cardlytics (CDLX) stake by 88% in Q1 2026, selling an estimated $119K and leaving 1,592 shares worth $16.7K. The position accounts for ﹤0.01% of the portfolio, ranked #12886.

Susquehanna International Group first reported a position in CDLX in Q3 2019 and has held it in 24 quarters since. The position peaked at $4.22M in Q4 2020. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • Susquehanna International Group held 1,592 shares of Cardlytics worth $16.7K as of Q1 2026.
  • Susquehanna International Group sold 12,195 Cardlytics shares in Q1 2026, an estimated $119K.
  • Cardlytics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12886 holding.
  • Susquehanna International Group first reported a position in Cardlytics in Q3 2019 and has held it in 24 quarters since.
  • Susquehanna International Group's Cardlytics position peaked at $4.22M in Q4 2020.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.